HIFEM in Pospartum (High Intensity Focused Electro-Magnetic Technology)
NCT: NCT07528560 · RECRUITING
Brief Summary
The goal of this non-randomized community clinical trial is to test how effective HIFEM (High Intensity Focused Electromagnetic) technology (BTL Emsella) is in strengthening pelvic floor muscles. The study focuses on first-time mothers who have recently given birth (postpartum) via vaginal delivery and are not showing symptoms of dysfunction. The main question this study aims to answer is: \- Can pelvic floor strength be restored after being exposed to weakening risk factors like pregnancy and childbirth? How to study works; The researcher will compare two groups of women to see how their muscles recover: 1. Those who receive the Emsella HIFEM treatment. 2. Those who follow their natural recovery without the treatment. Participant Journey: * Initial Check-up: Once the standard 6-week postpartum recovery period (quarantine) is over. * Eligibility: The researcher checks if participants meet the study criteria. * Decision: After receiving full information and signing a consent form, participants decide whether or not to undergo the treatment. * Final Results: A follow-up assessment is conducted 3 months after the first visit, regardless of whether the treatment was used.
Frequently Asked Questions
What is HIFEM in Pospartum (High Intensity Focused Electro-Magnetic Technology)?
HIFEM in Pospartum (High Intensity Focused Electro-Magnetic Technology) is a clinical trial registered under NCT07528560. Current status: RECRUITING.
What is the status of NCT07528560?
The current status of NCT07528560 (HIFEM in Pospartum (High Intensity Focused Electro-Magnetic Technology)) is: RECRUITING.
When did HIFEM in Pospartum (High Intensity Focused Electro-Magnetic Technology) start?
HIFEM in Pospartum (High Intensity Focused Electro-Magnetic Technology) started on 2026-04.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.